Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    MS Drugs May Not Delay Disability - More Contradictory News
    avatar
    Elizabeth_WebMD_Staff posted:
    According to a new study, patients treated with interferon beta, the drugs to help prevent relapses, were no less likely than untreated patients to progress to the point where they required a cane.

    Multiple Sclerosis Drugs May Not Delay Disability

    Researches in British Columbia and Italy appear to have conflicting results. Once again, we hope that wider, comprehensive research is conducted.

    Share your thoughts on this news.

    Elizabeth
    Reply
     
    avatar
    hackwriter responded:
    The research community is already aware that we don't all respond equally to interferons or to glatiramer acetate. These conflicting studies might be a reflection of that.

    There is a recent study published in the July 12 issue of the New England Journal of Medicine about the discovery of a particular kind of antibody found in the blood of MS patients that are not present in other autoimmune diseases, the significance of which is that it might help to identify what kinds of drugs will benefit us via a blood test during the diagnostic phase. Getting the right treatment early in the disease process might help us delay having to use a walking aid.

    Kim
     
    avatar
    Elizabeth_WebMD_Staff replied to hackwriter's response:
    Hi Kim -

    I also noticed that study last week but think I read about it in Neurology???? Oh, and you also posted about it here -

    Scientists Pinpoint Antibody that may be Specific to MS

    This antibody news seems like it would take center stage over some of these other small patient population studies.

    Elizabeth
     
    avatar
    hackwriter replied to Elizabeth_WebMD_Staff's response:
    Elizabeth,

    I agree that the antibody study is more significant and builds on the genetic studies that are identifying biomarkers for MS.

    The overall significance of these is that they will help move treatment trends from a once-size-fits-all therapy to individualized treatment, one that delivers a "molecular cocktail" designed especially for that patient.

    Kim


    Featuring Experts

    Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

    Helpful Tips

    Help Our Community & Experts Help You - Please Read
    Welcome to the WebMD Multiple Sclerosis Community! Please don't respond to this discussion. Instead, please read before you start your ... More
    Was this Helpful?
    107 of 109 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.